Jalil, Esnedam M.
HRN: 18-77-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/25/2022
08/31/2022
IV
500mg
Q8hrs
T/C Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes